Lionberger JM - Search Results

1

The c-Fes family of protein-tyrosine kinases.

Smithgall TE, Rogers JA, Peters KL, Li J, Briggs SD, Lionberger JM, Cheng H, Shibata A, Scholtz B, Schreiner S, Dunham N. Smithgall TE, et al. Among authors: lionberger jm. Crit Rev Oncog. 1998;9(1):43-62. doi: 10.1615/critrevoncog.v9.i1.40. Crit Rev Oncog. 1998. PMID: 9754447 Review.

2

Oligomerization of the Fes tyrosine kinase. Evidence for a coiled-coil domain in the unique N-terminal region.

Read RD, Lionberger JM, Smithgall TE. Read RD, et al. Among authors: lionberger jm. J Biol Chem. 1997 Jul 18;272(29):18498-503. doi: 10.1074/jbc.272.29.18498. J Biol Chem. 1997. PMID: 9218495 Free article.

3

The c-Fes protein-tyrosine kinase suppresses cytokine-independent outgrowth of myeloid leukemia cells induced by Bcr-Abl.

Lionberger JM, Smithgall TE. Lionberger JM, et al. Cancer Res. 2000 Feb 15;60(4):1097-103. Cancer Res. 2000. PMID: 10706130

4

Transformation of myeloid leukemia cells to cytokine independence by Bcr-Abl is suppressed by kinase-defective Hck.

Lionberger JM, Wilson MB, Smithgall TE. Lionberger JM, et al. J Biol Chem. 2000 Jun 16;275(24):18581-5. doi: 10.1074/jbc.C000126200. J Biol Chem. 2000. PMID: 10849448 Free article.

5

Advances in the management of patients with non-Hodgkin's lymphoma.

Lionberger JM, Armitage JO. Lionberger JM, et al. Expert Rev Anticancer Ther. 2001 Jun;1(1):43-52. doi: 10.1586/14737140.1.1.43. Expert Rev Anticancer Ther. 2001. PMID: 12113132 Review.

6

Myeloid sarcoma without circulating leukemia mimicking gastrointestinal malignancy and lymphoma.

Ravulapati S, Siegel C, Dara A, Lionberger JM. Ravulapati S, et al. Among authors: lionberger jm. Hematol Rep. 2018 Jun 14;10(2):7040. doi: 10.4081/hr.2018.7040. eCollection 2018 May 14. Hematol Rep. 2018. PMID: 30046410 Free PMC article.

7

Dysregulation of sphingolipid metabolism contributes to bortezomib-induced neuropathic pain.

Stockstill K, Doyle TM, Yan X, Chen Z, Janes K, Little JW, Braden K, Lauro F, Giancotti LA, Harada CM, Yadav R, Xiao WH, Lionberger JM, Neumann WL, Bennett GJ, Weng HR, Spiegel S, Salvemini D. Stockstill K, et al. Among authors: lionberger jm. J Exp Med. 2018 May 7;215(5):1301-1313. doi: 10.1084/jem.20170584. Epub 2018 Apr 27. J Exp Med. 2018. PMID: 29703731 Free PMC article.

8

Acute myeloid leukemia induction with cladribine: Outcomes by age and leukemia risk.

Schoen MW, Woelich SK, Braun JT, Reddy DV, Fesler MJ, Petruska PJ, Freter CE, Lionberger JM. Schoen MW, et al. Among authors: lionberger jm. Leuk Res. 2018 May;68:72-78. doi: 10.1016/j.leukres.2018.03.005. Epub 2018 Mar 6. Leuk Res. 2018. PMID: 29574395

9

Efficacy and Toxicity of Induction Therapy with Cladribine, Idarubicin, and Cytarabine (IAC) for Acute Myeloid Leukemia.

Woelich SK, Braun JT, Schoen MW, Ramlal R, Freter CE, Petruska PJ, Lionberger JM. Woelich SK, et al. Among authors: lionberger jm. Anticancer Res. 2017 Feb;37(2):713-717. doi: 10.21873/anticanres.11368. Anticancer Res. 2017. PMID: 28179321

10

Tumor lysis syndrome and metastatic melanoma.

Meeks MW, Hammami MB, Robbins KJ, Cheng KL, Lionberger JM. Meeks MW, et al. Among authors: lionberger jm. Med Oncol. 2016 Dec;33(12):134. doi: 10.1007/s12032-016-0854-5. Epub 2016 Nov 2. Med Oncol. 2016. PMID: 27807723

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters